NAV

I-Coeleneterazine

Identification

Generic Name
I-Coeleneterazine
DrugBank Accession Number
DB04146
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Similar Structures
Weight
Average: 567.3751
Monoisotopic: 567.065499627
Chemical Formula
C26H22IN3O4
Synonyms
Not Available
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available
InChI Key
VKJBKKSOPAEBAT-GJZUVCINSA-N
InChI
InChI=1S/C26H22IN3O4/c27-20-10-6-18(7-11-20)15-26(34-33)25(32)30-16-23(19-8-12-21(31)13-9-19)28-22(24(30)29-26)14-17-4-2-1-3-5-17/h1-13,16,22,28,31,33H,14-15H2/t22-,26+/m1/s1
IUPAC Name
(2S,8R)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-[(4-iodophenyl)methyl]-2H,3H,7H,8H-imidazo[1,2-a]pyrazin-3-one
SMILES
[H][C@]1(CC2=CC=CC=C2)NC(=CN2C(=O)[C@](CC3=CC=C(I)C=C3)(OO)N=C12)C1=CC=C(O)C=C1

References

General References
Not Available
PubChem Compound
49866867
PubChem Substance
46507018
ChemSpider
25061043
ZINC
ZINC000103537754
PDBe Ligand
CZI
PDB Entries
1uhi

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00352 mg/mLALOGPS
logP4.41ALOGPS
logP5.23Chemaxon
logS-5.2ALOGPS
pKa (Strongest Acidic)9.5Chemaxon
pKa (Strongest Basic)-3.3Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count6Chemaxon
Hydrogen Donor Count3Chemaxon
Polar Surface Area94.39 Å2Chemaxon
Rotatable Bond Count6Chemaxon
Refractivity137.12 m3·mol-1Chemaxon
Polarizability52.83 Å3Chemaxon
Number of Rings5Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.7897
Blood Brain Barrier-0.5437
Caco-2 permeable-0.6337
P-glycoprotein substrateSubstrate0.7154
P-glycoprotein inhibitor INon-inhibitor0.7212
P-glycoprotein inhibitor IINon-inhibitor0.6789
Renal organic cation transporterNon-inhibitor0.8374
CYP450 2C9 substrateNon-substrate0.823
CYP450 2D6 substrateNon-substrate0.8146
CYP450 3A4 substrateSubstrate0.5815
CYP450 1A2 substrateNon-inhibitor0.546
CYP450 2C9 inhibitorNon-inhibitor0.6201
CYP450 2D6 inhibitorNon-inhibitor0.8273
CYP450 2C19 inhibitorNon-inhibitor0.5588
CYP450 3A4 inhibitorNon-inhibitor0.5827
CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.8003
Ames testNon AMES toxic0.6086
CarcinogenicityNon-carcinogens0.7847
BiodegradationNot ready biodegradable1.0
Rat acute toxicity2.6197 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.983
hERG inhibition (predictor II)Non-inhibitor0.8171
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0159-0000090000-664a8b1e2518576c6a47
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-0000090000-d5487903f4bcb892cb56
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00lr-0000090000-73431bc967e956f748d3
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0py0-2487690000-1aee29e15633aa026290
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0159-0043290000-79f11e71b5c0e13efd2b
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-0590100000-a760480ce790bbaf6af8
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-214.27557
predicted
DeepCCS 1.0 (2019)
[M+H]+216.67116
predicted
DeepCCS 1.0 (2019)
[M+Na]+222.58427
predicted
DeepCCS 1.0 (2019)

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52